Molecular and genetic approach to Alzheimer’s disease

Abstract

Alzheimer's disease (AD) is a complex neurodegenerative condition marked by gradual cognitive decline and memory impairment, posing significant challenges for healthcare and society globally. Advances in genomic research, such as GWAS, have uncovered additional candidate genes influencing AD susceptibility, revealing the intricate and varied genetic underpinnings of the disease. Understanding AD's genetic foundation is pivotal for targeted treatments, early detection, and personalized interventions. Ongoing research aims to untangle the complex interplay of genetic, environmental, and neurobiological factors in AD, paving the way for more effective therapeutic and preventive strategies.